Nutra Pharma Corp (NPHC)

[Steppenwolf$$$]

Our Condensed Consolidated Financial Statements are presented on a going concern basis, which contemplate the realization of assets
and satisfaction of liabilities in the normal course of business. We have experienced recurring, significant losses from operations, and
have an accumulated deficit of $54,299,536 at March 31, 2017. In addition, we have a working capital deficit of of $5,056,090 and a
stockholders’ deficit of $5,041,224 at March 31, 2017.